Interserve, the international support services and construction group, has been awarded a contract with The Christie NHS Foundation Trust to design, construct and co-ordinate a UK high energy Proton Beam Therapy facility in Manchester. Subject to approval, construction work is planned to start on site in 2016, completing in 2018. The project is part of a ProCure 21+ framework, with Interserve appointed Principal Supply Chain Partner.
Proton beam therapy is a specialist form of radiotherapy which can very precisely target certain cancers, increasing success rates and reducing side-effects. Its introduction to the UK will bring the treatment closer to patients who currently have to travel abroad to receive it.
The team, consisting of HKS Architect, ARUP Engineers and Gleeds Cost Consultants, will draw on their experience and research to deliver Proton Beam Therapy in the UK. Over a two year period, Interserve travelled to various sites internationally to capture experience and lessons learnt from similar facilities, talking to clinicians and contractors, in order to enable a local team to deliver what the client required. Currently, Interserve and its partners are supporting and responding to specialist equipment vendors to provide concept designs.
The competition was posted by WAN’s Business Information Service in December 2011.